Antiviral therapy and prevention of influenza;Antivirale therapie und prophylaxe der influenza

Chemotherapie Journal

Volumn 12, Issue 1, 2003, Pages 1-3

  Wutzler, P ^a   Kossow, K D ^b   Lode, H ^c   Ruf, B ^d   Scholz, H ^e   Vogel, G E ^f  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Bundesvorstand Allgemein Deu   (Germany)

^c Zentralklinik Emil von Behring   (Germany)

^d Klinikum St Georg   (Germany)

^e Deu Gesellschaft Padiat Infektiol   (Germany)

^f Internistische Praxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; ZANAMIVIR;

ANTIVIRAL ACTIVITY; CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; PROPHYLAXIS; SHORT SURVEY; TREATMENT PLANNING;

EID: 0037323818     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Hayden FG, Atmar RL, Schilling M et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.
2. Hayden FG, Gubareva LV, Monto AS et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med 2000;343:1282-9.
3. Hedrick JA, Barzilai A, Behre U et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J 2000;19:410-7.
4. Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults (Cochrane Review).Cochrane Database Syst Rev 2002;(3):CD001169.
5. MIST(Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998;352:1877-881.
6. Monto AS, Fleming DM, Henry D et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999;180:254-61.
7. Monto AS, Robinson DP, Herlocher ML et al. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999;282:31-5.
8. Murphy KR, Eivindson A, Paukens K et al. Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease. Clin Drug Invest 2000;20:337-40.
9. Nicholson KG, Aoki FY, Osterhaus AD et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-50.
10. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000;283:1016-24.
11. Welliver R, Monto AS, Carewicz et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-54.
12. Whitley RJ, Hayden FG, Reisinger KS et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.
13. Zambon M, Hays J, Webster A et al. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med 2001;161:2116-22.